Photobiomodulation (670 nm) for Aging Retina: Lifespan Signals from Flies to Mammals

This audio article is from VisualFieldTest.com.Read the full article here: https://visualfieldtest.com/en/photobiomodulation-670-nm-for-aging-retina-lifespan-signals-from-flies-to-mammalsTest your visual field online: https://visualfieldtest.comSupport the show so new episodes keep coming: https://www.buzzsprout.com/2563091/supportExcerpt:Introduction As we age, eye cells gradually lose energy and function, partly because their mitochondria (the cell’s “batteries”) become weaker (). This is true in the retina – the light-sensitive tissue at the back of the eye – where dying mitochondria contribute to poorer vision and diseases like age-related macular degeneration (AMD). Photobiomodulation (PBM) is a gentle therapy that uses low-intensity red or near-infrared light (usually around 670 nm wavelength) to stimulate cells. Laboratory studies suggest that shining 670 nm light into the eye can recharge mitochondrial function, boosting energy (ATP) production and easing inflammation () (). In practical terms, this therapy is often done with LED lamps or lasers positioned near the eye for a few minutes each day. Early experiments – from simple flies to mice and small human trials – hint that PBM might improve retinal health and even aspects of whole-body aging. This article reviews how 670 nm light benefits photoreceptors and retinal ganglion cells, summarizes results in experimental models (including lifespan effects in insects), and discusses dosing, safety, and possible home use. Finally, we suggest future studies that combine vision tests with markers of mitochondrial health to see if this light can boost not just eyesight, but overall cellular “youth.” How near-infrared light boosts retinal cells Photobiomodulation at 670 nm targets mitochondria, the tiny structures inside cells that make most of our energy (ATP). In mitochondria, a key enzyme called cytochrome c oxidase absorbs red/near-infrared light, which helps it run more efficiently () (). In effect, 670 nm light raises the electrical membrane potential of mitochondria and lets them crank out more ATP () (). Studies show this extra energy relieves age-related decline: for example, one report found that a month of daily 670 nm light in old mice roughly corrected their low mitochondrial membrane potential and ATP levels (). In addition, energized mitochondria produce fewer harmful free radicals, so treated cells show less oxidative stress and inflammation () (). Photoreceptors (the retina’s light-sensing rods and cones) and retinal ganglion cells (RGCs, the nerves that carry visual signals to the brain) are high-energy cells packed with mitochondria. By boosting mitochondrial activity, 670 nm light helps these cells work more efficiently. Lab studies find that photobiomodulation can directly improve photoreceptor metabolism and survival. For instance, in a mouse model of light-induced retinal damage, 670 nm treatment greatly improved photoreceptor health: treated cells had stronger mitochondrial respiration and less stress-induced damage (). Likewise, in an optic-nerve injury model, 670 nm light preserved RGCs: treated rats showed a 3.4-fold increase in visual signal strength and 1.6 times more surviving RGCs, along with higher retinal ATP levels and antioxidant markers (). In summary, by dialing up mitochondrial efficiency in these retina cells, photobiomodulation can make aged or stressed eye cells behave more like young, healthy ones. Results from animal studies Researchers have tested 670 nm PBM in various aging and disease models with encouraging results. In aged mice without injury, daily 670 nm exposure for one month led to markedly better retinal function:Support the show